Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT

被引：0
|
作者：
Hendrik Rathke
Clemens Kratochwil
Ralph Hohenberger
Frederik Lars Giesel
Frank Bruchertseifer
Paul Flechsig
Alfred Morgenstern
Matti Hein
Peter Plinkert
Uwe Haberkorn
Olcay Cem Bulut
机构：
[1] Heidelberg University Hospital,Department of Nuclear Medicine
[2] Heidelberg University Hospital,Department of Otorhinolaryngology, Head and Neck Surgery (ORL
[3] Joint Research Centre,HNS)
[4] SLK Klinikum Am Gesundbrunnen,Directorate for Nuclear Safety and Security, European Commission
[5] German Cancer Research Center (DKFZ),Department of Otorhinolaryngology, Head and Neck Surgery
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
PSMA-617; Ac-225; TAT; Xerostomia; PSMA-RLT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：139 / 147
页数：8
相关论文
共 41 条
  • [31] Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
    Sen, Ishita
    Thakral, Parul
    Tiwari, Priya
    Pant, Vineet
    Das, Subha Shankar
    Manda, Divya
    Raina, Vinod
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (07) : 794 - 810
  • [32] Clinical-Prostate cancer Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
    van der Doelen, Maarten J.
    Mehra, Niven
    van Oort, Inge M.
    Looijen-Salamon, Monika G.
    Janssen, Marcel J. R.
    Custers, Jose A. E.
    Slootbeek, Peter H. J.
    Kroeze, Leonie, I
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Haberkorn, Uwe
    Kratochwil, Clemens
    Nagarajah, James
    Gerritsen, Winald R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 729.e7 - 729.e16
  • [33] Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Knoesen, Otto
    Mahapane, Johncy
    Davis, Cindy
    Reyneke, Florette
    Maes, Alex
    Kratochwil, Clemens
    Lengana, Thabo
    Giesel, Frederik L.
    Van de Wiele, Christophe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 62 - 69
  • [34] Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients
    Das, Tapas
    Guleria, Mohini
    Parab, Anil
    Kale, Chanchala
    Shah, Hina
    Sarma, Haladhar D.
    Lele, Vikram R.
    Banerjee, Sharmila
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (05) : 296 - 302
  • [35] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, T.
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S645 - S645
  • [36] Combined PRLT using Ac-225 and Lu-177 labeled PSMA-617 (TANDEM-PRLT) in end-stage metastatic prostate cancer: a concept to reduce salivary gland toxicity?
    Langbein, Thomas
    Kulkarni, Harshad
    Singh, Aviral
    Schuchardt, Christiane
    Zhang, Jingjing
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [37] Assessment of response, clinical evaluation and toxicity of radioligand therapy (RLT) with 177-Lutetium-DKFZ-617-labelled Prostate specific membrane antigen (177-Lu-DKFZ-617-PSMA) for metastatic castrate resistant prostate cancer (mCRPC): An initial experience in Jaslok
    Rathore, H.
    Shah, H.
    Aland, P.
    Chaudhuri, P.
    Bharadwaj, T.
    Kale, C.
    Shekar, C.
    Parab, A.
    Paltro, S.
    Korepu, P.
    James, V. M.
    Lele, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S414 - S414
  • [38] Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy
    Burgard, Caroline
    Khreish, Fadi
    Dahlmanns, Lukas
    Blickle, Arne
    Bastian, Moritz B.
    Speicher, Tilman
    Maus, Stephan
    Schaefer-Schuler, Andrea
    Bartholomae, Mark
    Petto, Sven
    Ezziddin, Samer
    Rosar, Florian
    CANCERS, 2024, 16 (20)
  • [39] Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention
    Popma, JJ
    Cox, N
    Hauptmann, KE
    Reifart, N
    Virmani, R
    Emira, K
    Murphy, S
    Gibson, CM
    Grube, E
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2002, 57 (02) : 125 - 134
  • [40] Clinical outcome in patients undergoing stenting of saphenous vein grafts using the TriActiv™ balloon-protection system:: Initial US and European experience
    Carrozza, JP
    Lancelin, B
    Caussin, C
    Braun, P
    Kussmaul, W
    George, B
    Uretsky, B
    Braden, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 51A - 51A
12345